Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Additional information

In vitro:

The substance Heptadecanol N was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli ( TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA), in a reverse mutation assay according to OECD 471 guideline (BASF, 2007). The test substance was tested at doses ranging from 20 μg to 5 000 μg/plate in the standard plate test (SPT) and the preincubation test (PIT) both with and without metabolic activation (Aroclor-induced rat liver S9 mix). Precipitation of the test substance was found from 500 μg/plate onward with and without S9 mix. A weak bacteriotoxic effect was occasionally observed depending on the strain and test conditions from about 2 500 μg/plate onward. An increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the preincubation test either without S9 mix or after the addition of a metabolizing system. According to the results of the present study, the test substance Heptadecanol N is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay under the experimental conditions chosen here.

In vivo:

This information is not available


Short description of key information:
Ames-Test: negative (BASF, 2007)

Endpoint Conclusion: No adverse effect observed (negative)

Justification for classification or non-classification

No mutagenicity was observed in an Ames test according to OECD 471 guideline. Therefore, the test substance has not to be classified according to EU (67/548/EEC)- and CLP (1272/2008/EC) requirements for this endpoint.